0001209191-23-037604.txt : 20230615 0001209191-23-037604.hdr.sgml : 20230615 20230615201752 ACCESSION NUMBER: 0001209191-23-037604 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230613 FILED AS OF DATE: 20230615 DATE AS OF CHANGE: 20230615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chung Christine CENTRAL INDEX KEY: 0001775295 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36740 FILM NUMBER: 231019112 MAIL ADDRESS: STREET 1: C/O FIBROGEN, INC. STREET 2: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIBROGEN INC CENTRAL INDEX KEY: 0000921299 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-978-1200 MAIL ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-13 0 0000921299 FIBROGEN INC FGEN 0001775295 Chung Christine C/O FIBROGEN, INC. 409 ILLINOIS ST. SAN FRANCISCO CA 94158 0 1 0 0 SVP, China Operations 1 Common Stock 2023-06-13 4 S 0 6250 17.60 D 242577 D Common Stock 2023-06-14 4 S 0 5250 16.66 D 237327 D Common Stock 2023-06-14 4 S 0 1000 17.46 D 236327 D Shares sold pursuant to a 10b5-1 trading plan. The shares were sold at prices ranging from $17.31 to $18.18. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The shares were sold at prices ranging from $16.34 to $17.32. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The shares were sold at prices ranging from $17.37 to $17.61. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Cecelia Monoarfa-Taime, Attorney-in-fact 2023-06-15